Manchin-Schumer plan would increase medicine costs while killing innovation

Published




Among the many wrongheaded features of the Manchin-Schumer tax-and-spendathon bill being pushed in Congress right now, the one on prescription drug pricing is a deadly vampire of a proposal that, for 16 years, has refused to stay deceased.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.